Status:
UNKNOWN
Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
Lead Sponsor:
Hospital do Servidor Publico Estadual
Conditions:
Deep Venous Thrombosis
Colonic Cancer
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The chemoprophylaxis of deep vein thrombosis (DVT) with subcutaneous low-molecular-weight heparin (enoxaparin) in the postoperative period of elective surgeries is already well established in the lite...
Detailed Description
There are already robust studies in the literature demonstrating the efficacy and safety of using Rivaroxaban 10mg once a day in the prevention of deep vein thrombosis of the lower limbs in patients u...
Eligibility Criteria
Inclusion
- Patients in post-operative surgery for colonic cancer.
- No contraindication for anticoagulation usage.
- Absence of renal or hepatic failure.
Exclusion
- Pregnancy,
- age \< 18 years,
- contraindication to the use of anticoagulants, -failure to complete the informed consent form. -
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05303818
Start Date
June 1 2022
End Date
June 1 2024
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital do Servidor Público Estadual de São Paulo
São Paulo, São Paulo, Brazil, 04028-000